Correction: The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells (PLoS ONE (2014) 9, 5 (e92596) DOI:10.1371/journal.pone.0092596);The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Redmer, Torben ^a   Welte, Yvonne ^a   Behrens, Diana ^b   Fichtner, Iduna ^b   Przybilla, Dorothea ^a   Wruck, Wasco ^a   Yaspo, Marie Laure ^c   Lehrach, Hans ^c   Schäfer, Reinhold ^a   Regenbrecht, Christian R A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Experimental Pharmacology and Oncology Berlin Buch GmbH   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR RECEPTOR CD271; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NERVE PROTEIN; NGFR PROTEIN, HUMAN; PEPTIDE; SOX10 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CD133 GENE; CELL HETEROGENEITY; CELL SURFACE; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NEURAL CREST CELL; NONHUMAN; PLASTICITY; ANIMAL; BIOSYNTHESIS; CANCER STEM CELL; CLINICAL TRIAL; FEMALE; GENE SILENCING; GENETICS; MALE; MELANOMA; META ANALYSIS (TOPIC); METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; MALE; MELANOMA; META-ANALYSIS AS TOPIC; MICE; MICE, INBRED NOD; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; RECEPTORS, NERVE GROWTH FACTOR; SOXE TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84900385297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105274     Document Type: Erratum

References (53)

1. Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, et al. (2009) Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15: 294-303.
2. Kim J, Lo L, Dormand E, Anderson DJ (2003) SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38: 17- 31.
3. Sauka-Spengler T, Bronner-Fraser M (2008) A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol 9: 557-568. (Pubitemid 351881841)
4. Zabierowski SE, Fukunaga-Kalabis M, Li L, Herlyn M (2011) Dermis-derived stem cells: a source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res 24: 422-429.
5. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
6. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. (Pubitemid 44949604)
7. Coskun V, Wu H, Blanchi B, Tsao S, Kim K, et al. (2008) CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci U S A 105: 1026-1031. (Pubitemid 351282075)
8. Rappa G, Fodstad O, Lorico A (2008) The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26: 3008-3017.
9. Shakhova O, Zingg D, Schaefer SM, Hari L, Civenni G, et al. (2012) Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol 14: 882-890.
10. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111. (Pubitemid 33041634)
11. Xin HW, Hari DM, Mullinax JE, Ambe CM, Koizumi T, et al. (2012) Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division. Stem Cells 30: 591-598.
12. Satzger I, Volker B, Meier A, Schenck F, Kapp A, et al. (2007) Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol 31: 1175-1180. (Pubitemid 47207119)
13. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, et al. (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510-523.
14. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
15. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, et al. (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71: 3098-3109.
16. Mundell NA, Labosky PA (2011) Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Development 138: 641-652.
17. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT (2011) Anti-apoptosis and cell survival: a review. Biochim Biophys Acta 1813: 238-259.
18. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868. (Pubitemid 28124064)
19. Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, et al. (2011) Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis 2: e200.
20. John N, Cinelli P, Wegner M, Sommer L (2011) Transforming growth factor beta-mediated Sox10 suppression controls mesenchymal progenitor generation in neural crest stem cells. Stem Cells 29: 689-699.
21. Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, et al. (2010) GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 102: 1148-1159.
22. Girouard SD, Laga AC, Mihm MC, Scolyer RA, Thompson JF, et al. (2012) SOX2 contributes to melanoma cell invasion. Lab Invest 92: 362-370.
23. Ueno Y, Sakurai H, Tsunoda S, Choo MK, Matsuo M, et al. (2008) Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells. Int J Cancer 123: 340-347. (Pubitemid 351842018)
24. Das SK, Bhutia SK, Azab B, Kegelman TP, Peachy L, et al. (2013) MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma. Cancer Res 73: 844-854.
25. Stove C, Vanrobaeys F, Devreese B, Van Beeumen J, Mareel M, et al. (2004) Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition. Oncogene 23: 5330-5339. (Pubitemid 39005808)
26. Ho H, Aruri J, Kapadia R, Mehr H, White MA, et al. (2012) RhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damage. Cancer Res 72: 5516-5528.
27. Sanyas I, Bozon M, Moret F, Castellani V (2012) Motoneuronal Sema3C is essential for setting stereotyped motor tract positioning in limb-derived chemotropic semaphorins. Development 139: 3633-3643.
28. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, et al. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20: 3426-3439. (Pubitemid 44969160)
29. Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, et al. (2012) Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest. BMC Cancer 12: 321.
30. Carney TJ, Dutton KA, Greenhill E, Delfino-Machin M, Dufourcq P, et al. (2006) A direct role for Sox10 in specification of neural crest-derived sensory neurons. Development 133: 4619-4630. (Pubitemid 46063075)
31. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, et al. (2006) Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125: 1269-1281. (Pubitemid 43949521)
32. Kanehira M, Harada Y, Takata R, Shuin T, Miki T, et al. (2007) Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 26: 6448-6455. (Pubitemid 47494219)
33. Aoki Y, Saint-Germain N, Gyda M, Magner-Fink E, Lee YH, et al. (2003) Sox10 regulates the development of neural crest-derived melanocytes in Xenopus. Dev Biol 259: 19-33. (Pubitemid 36703141)
34. Prasad MK, Reed X, Gorkin DU, Cronin JC, McAdow AR, et al. (2011) SOX10 directly modulates ERBB3 transcription via an intronic neural crest enhancer. BMC Dev Biol 11: 40.
35. Yokoyama S, Takeda K, Shibahara S (2006) SOX10, in combination with Sp1, regulates the endothelin receptor type B gene in human melanocyte lineage cells. FEBS J 273: 1805-1820. (Pubitemid 43779832)
36. Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ (2000) Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet 107: 1-6. (Pubitemid 30598938)
37. Betancur P, Sauka-Spengler T, Bronner M (2011) A Sox10 enhancer element common to the otic placode and neural crest is activated by tissue-specific paralogs. Development 138: 3689-3698.
38. Stolt CC, Lommes P, Hillgartner S, Wegner M (2008) The transcription factor Sox5 modulates Sox10 function during melanocyte development. Nucleic Acids Res 36: 5427-5440.
39. Dorsky RI, Raible DW, Moon RT (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14: 158-162. (Pubitemid 30070981)
40. Willert J, Epping M, Pollack JR, Brown PO, Nusse R (2002) A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2: 8.
41. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, et al. (2009) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28: 209-218.
42. You H, Ding W, Rountree CB (2010) Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology 51: 1635-1644.
43. Regenbrecht C, Welte Y, Hugel R, Trefzer U, Losch FO, et al. (2008) Cancer stem cells in melanoma. Ecancermedicalscience 2: 114.
44. Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, et al. (1996) Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol 19: 192-205. (Pubitemid 26234613)
45. Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed) 15: 166-179.
46. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, et al. (2006) More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 35: 297-325. (Pubitemid 44266778)
47. Boiko AD (2013) Isolation of melanoma tumor-initiating cells from surgical tissues. Methods Mol Biol 961: 253-259.
48. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, et al. (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489. (Pubitemid 40663843)
49. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
50. Lee G, Kim H, Elkabetz Y, Al Shamy G, Panagiotakos G, et al. (2007) Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 25: 1468-1475. (Pubitemid 350233140)
51. Konig A, Gradl D, Kuhl M, Wedlich D (2000) The HMG-box transcription factor XTcf-4 demarcates the forebrain-midbrain boundary. Mech Dev 93: 211-214. (Pubitemid 30216515)
52. Meier P, Koedood M, Philipp J, Fontana A, Mitchell PJ (1995) Alternative mRNAs encode multiple isoforms of transcription factor AP-2 during murine embryogenesis. Dev Biol 169: 1-14.
53. Labbe E, Lock L, Letamendia A, Gorska AE, Gryfe R, et al. (2007) Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 67: 75-84. (Pubitemid 46142761)